Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
38.1M
-
Shares change
-
-6.95M
-
Total reported value, excl. options
-
$106M
-
Value change
-
-$9.11M
-
Put/Call ratio
-
0.88
-
Number of buys
-
62
-
Number of sells
-
-63
-
Price
-
$2.78
Significant Holders of ImmunityBio, Inc. - COM (IBRX) as of Q2 2023
164 filings reported holding IBRX - ImmunityBio, Inc. - COM as of Q2 2023.
ImmunityBio, Inc. - COM (IBRX) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.1M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (10.3M shares), BlackRock Inc. (9.5M shares), STATE STREET CORP (2.78M shares), GEODE CAPITAL MANAGEMENT, LLC (2.73M shares), JPMORGAN CHASE & CO (1.48M shares), NORTHERN TRUST CORP (1.16M shares), CREDIT SUISSE AG/ (1.02M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (979K shares), NATIONAL BANK OF CANADA /FI/ (795K shares), and ALLEN HOLDING INC /NY (688K shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.